Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa

Clinical Infectious Diseases

Volumn 58, Issue 10, 2014, Pages 1467-1472

  Manicklal, S ^a,b   Van Niekerk, A M ^a   Kroon, S M ^a   Hutto, C ^b   Novak, Z ^b   Pati, S K ^b   Chowdhury, N ^b   Hsiao, N Y ^a   Boppana, S B ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c University of Alabama at Birmingham   (United States)

Author keywords

Antiretroviral prophylaxis; Congenital CMV; HIV; Prevalence; South Africa

Indexed keywords

NEVIRAPINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BIRTH; BIRTH WEIGHT; CD4 LYMPHOCYTE COUNT; CLINICAL STUDY; CONCEPTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT DISEASE; INFANT FEEDING; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN; PERINATAL PERIOD; PREGNANCY; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REAL TIME POLYMERASE CHAIN REACTION; SALIVA; SECOND TRIMESTER PREGNANCY; SINGLE DRUG DOSE; SMALL FOR DATE INFANT; SOUTH AFRICA; UNIVARIATE ANALYSIS; VIRUS LOAD; VIRUS TRANSMISSION; AIDS RELATED COMPLEX; CYTOMEGALOVIRUS INFECTIONS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; ISOLATION AND PURIFICATION; PREGNANCY COMPLICATIONS, INFECTIOUS; TRANSMISSION; VERTICAL TRANSMISSION; VIROLOGY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SOUTH AFRICA; VIRAL LOAD; ZIDOVUDINE;

EID: 84899844249     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu096     Document Type: Article

References (21)

1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiologyof congenital cytomegalovirus (CMV) infection. Rev Med Virol2007; 17:253-76.
2. Dar L, Pati SK, Patro AR, et al. Congenital cytomegalovirus infection ina highly seropositive semi-urban population in India. Pediatr Infect DisJ 2008; 27:841-3.
3. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The "silent"global burden of congenital cytomegalovirus. Clin Microbiol Rev2013; 26:86-102.
4. van der Sande MA, Kaye S, Miles DJ, et al. Risk factors for and clinicaloutcome of congenital cytomegalovirus infection in a peri-urbanWest-African birth cohort. PLoS One 2007; 2:e492.
5. Doyle M, Atkins JT, Rivera-Matos IR. Congenital cytomegalovirus infectionin infants infected with human immunodeficiency virus type 1.Pediatr Infect Dis J 1996; 15:1102-6.
6. Guibert G, Warszawski J, Le Chenadec J, et al. Decreased risk of congenitalcytomegalovirus infection in children born to HIV-1-infectedmothers in the era of highly active antiretroviral therapy. Clin InfectDis 2009; 48:1516-25.
7. Duryea EL, Sanchez PJ, Sheffield JS, et al. Maternal human immunodeficiencyvirus infection and congenital transmission of cytomegalovirus.Pediatr Infect Dis J 2010; 29:915-8.
8. Kovacs A, Schluchter M, Easley K, et al. Cytomegalovirus infection andHIV-1 disease progression in infants born to HIV-1-infected women.Pediatric Pulmonary and Cardiovascular Complications of VerticallyTransmitted HIV Infection Study Group. N Engl J Med 1999; 341:77-84.
9. Gompels UA, Larke N, Sanz-Ramos M, et al. Human cytomegalovirusinfant infection adversely affects growth and development in maternallyHIV-exposed and unexposed infants in Zambia. Clin Infect Dis 2012;54:434-42.
10. Frederick T, Homans J, Spencer L, Kramer F, Stek A, Operskalski E. Theeffect of prenatal highly active antiretroviral therapy on the transmissionof congenital and perinatal/early postnatal cytomegalovirus amongHIV-infected and HIV-exposed infants. Clin Infect Dis 2012; 55:877-84.
11. Slyker JA, Lohman-Payne BL, John-Stewart GC, et al. Acute cytomegalovirusinfection in Kenyan HIV-infected infants. AIDS 2009; 23:2173-81.
12. Mwaanza N, Chilukutu L, Tembo J, et al. High rates of congenital cytomegalovirus(CMV) infections linked with maternal HIV infectionamong neonatal admissions at a large referral centre in sub-Saharan Africa.Clin Infect Dis 2013; 58:728-35.
13. National Antenatal Sentinel HIV and Syphilis Prevalence Survey inSouth Africa. Pretoria, South Africa: National Department of Health,2011.
14. Boppana SB, Ross SA, Shimamura M, et al. Saliva polymerase- chainreactionassay for cytomegalovirus screening in newborns. N Engl JMed 2011; 364:2111-8.
15. Mussi-Pinhata MM, Yamamoto AY, Moura Brito RM, et al. Birth prevalenceand natural history of congenital cytomegalovirus infection in ahighly seroimmune population. Clin Infect Dis 2009; 49:522-8.
16. Mocarski JE, Shenk T, Pass R. Cytomegaloviruses. In: Knipe D, HowleyP, eds. Field's virology. 5th ed. Philadelphia: Lippincott Williams andWilkins, 2007.
17. Griffiths PD. CMV as a cofactor enhancing progression of AIDS. J ClinVirol 2006; 35:489-92.
18. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load,zidovudine treatment, and the risk of transmission of human immunodeficiencyvirus type 1 from mother to infant. Pediatric AIDS ClinicalTrials Group Protocol 076 Study Group. N Engl J Med 1996; 335:1621-9.
19. Barron P, Pillay Y, Doherty T, et al. Eliminating mother-to-childHIV transmission in South Africa. Bull World Health Organ 2013;91:70-4.
20. Pinninti S, Ross S, Rodgers M, et al. Newborn CMV screening: salivaPCR identifies more infants with congenital CMV infection thanrapid culture. In: Pediatric Academic Societies Annual Meeting, Boston,MA, 29 April 2012.
21. Fox MP, Shearer K, Maskew M, et al. Treatment outcomes after 7 yearsof public-sector HIV treatment. AIDS 2012; 26:1823-8.